EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In vivo evaluation of a Nano-enabled therapeutic vitreous substitute for the precise delivery of triamcinolone to the posterior segment of the eye

Kruti Naik, Lisa Claire du Toit, Naseer Ally, Yahya Essop Choonara iD

Drug Delivery and Translational Research · 2024

DOI: 10.1007/s13346-024-01566-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Delivery and Translational Research, 2024. Verfasst von Kruti Naik und 3 weiteren Autor:innen. Beteiligte Einrichtung: Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Scienc…. Hauptthemen laut MEDLINE: Nanoparticles, Hydrogels, Hyaluronic Acid, Triamcinolone Acetonide. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of the Witwatersrand.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study focused on the design of a thermoresponsive, nano-enabled vitreous substitute for the treatment of retinal diseases. Synthesis of a hydrogel composed of hyaluronic acid and a poloxamer blend was undertaken. Poly(D,L-lactide-co-glycolide) acid nanoparticles encapsulating triamcinolone acetonide (TA) were synthesised with a spherical morphology and mean diameter of ~ 153 nm. Hydrogel fabrication and nanoparticle loading within the hydrogel was confirmed via physicochemical analysis. Gelation studies indicated that hydrogels formed in nine minutes and 10 min for the unloaded and nanoparticle-loaded hydrogels, respectively. The hydrogels displayed in situ gel formation properties, and rheometric viscoelastic studies indicated the unloaded and loaded hydrogels to have modulus values similar to those of the natural vitreous at 37 °C. Administration of the hydrogels was possible via 26G needles allowing for clinical application and drug release of triamcinolone acetonide from the nanoparticle-loaded hydrogel, which provided sustained in vitro drug release over nine weeks. The hydrogels displayed minimal swelling, reaching equilibrium swelling within 12 h for the unloaded hydrogel, and eight hours for the nanoparticle-loaded hydrogel. Biodegradation in simulated vitreous humour with lysozyme showed < 20% degradation within nine weeks. Biocompatibility of both unloaded and loaded hydrogels was shown with mouse fibroblast and human retinal pigment epithelium cell lines. Lastly, a pilot in vivo study in a New Zealand White rabbit model displayed minimal toxicity with precise, localised drug release behaviour, and ocular TA levels maintained within the therapeutic window for the 28-day investigation period, which supports the potential applicability of the unloaded and nanoparticle-loaded hydrogels as vitreous substitutes that function as drug delivery systems following vitrectomy surgery. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesHydrogelsHyaluronic AcidTriamcinolone AcetonideVitreous BodyAnimalsRabbitsPolylactic Acid-Polyglycolic Acid CopolymerPoloxamerMiceDrug LiberationDrug Delivery SystemsPosterior Eye SegmentHumansCell LineIntravitreal InjectionsPolyglycolic Acid

Stichwörter der Autor:innen

In situ hydrogelNanoparticlesPolymersRetinal detachmentTriamcinolone acetonideVitreous substitute

Substanzen

HydrogelsHyaluronic AcidTriamcinolone AcetonidePolylactic Acid-Polyglycolic Acid CopolymerPoloxamerPolyglycolic Acid

Autor:innen und Institutionen

  • Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, 7 York Road, Johannesburg, Parkto…
  • Division of Ophthalmology, Department of Neurosciences, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, 7 York Road, Johannesburg, Parktown, 2193, South Africa.

ORCID-Profile: Yahya Essop Choonara

Förderung

  • University of the Witwatersrand

Zitieren

APA

Naik, K., du Toit, L. C., Ally, N., & Choonara, Y. E. (2024). In vivo evaluation of a Nano-enabled therapeutic vitreous substitute for the precise delivery of triamcinolone to the posterior segment of the eye. Drug Delivery and Translational Research. https://doi.org/10.1007/s13346-024-01566-1

Vancouver

Naik K, du Toit LC, Ally N, Choonara YE. In vivo evaluation of a Nano-enabled therapeutic vitreous substitute for the precise delivery of triamcinolone to the posterior segment of the eye. Drug Delivery and Translational Research. 2024. doi:10.1007/s13346-024-01566-1

BibTeX
@article{Naik2024,
  author = {Naik, Kruti and du Toit, Lisa Claire and Ally, Naseer and Choonara, Yahya Essop},
  title = {In vivo evaluation of a Nano-enabled therapeutic vitreous substitute for the precise delivery of triamcinolone to the posterior segment of the eye},
  journal = {Drug Delivery and Translational Research},
  year = {2024},
  doi = {10.1007/s13346-024-01566-1}
}
Kostenlos starten →